Chemotherapy alone for laryngeal preservation - Is it possible?

Journal of Clinical Oncology

Volumn 27, Issue 12, 2009, Pages 1933-1934

  Forastiere, Arlene A ^a   Shaha, Ashok R ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IFOSFAMIDE; PACLITAXEL; SURVIVIN;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; DISEASE MARKER; DNA STRAND BREAKAGE; EDITORIAL; EXCISION REPAIR; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LARYNGEAL BIOPSY; LARYNGECTOMY; LARYNX CANCER; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; VOICE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; HUMANS; LARYNGEAL NEOPLASMS; REMISSION INDUCTION;

EID: 65349152520     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.9445     Document Type: Editorial

References (11)

1. Holsinger FC, Kies MS, Diaz EM, et al: Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol 27:1976- 1982, 2009
2. Laccourreye O, Brasnu D, Bassot V, et al: Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: Five-year results. J Clin Oncol 14:2331-2336, 1996
3. Laccourreye O, Veivers D, Bassot V, et al: Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure. Ann Otol Rhinol Laryngol 111:315-321; discussion 321-322, 2002
4. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685-1690, 1991
5. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003
6. Worden FP, Wolf G, Eisbruch A, et al: Chemo-selection of patients (pts) for organ preservation in advanced laryngeal cancer: Failure of chemotherapy (CT) as the sole treatment for complete histologic responders (CHR) to neoadjuvant chemotherapy. J Clin Oncol 24:295s, 2006 (suppl; abstr 5560)
7. al-Sarraf M, Kish JA, Ensley JF: The Wayne State University experience with adjuvant chemotherapy of head and neck cancer. Hematol Oncol Clin North Am 5:687-700, 1991
8. Forastiere AA: Randomized trials of induction chemotherapy: A critical review. Hematol Oncol Clin North Am 5:725-736, 1991
9. Urba S, Wolf G, Eisbruch A, et al: Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: A new treatment paradigm. J Clin Oncol 24:593-598, 2006
10. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial-EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996
11. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1999